Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — Cash Flow Quality Index
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Cash Flow Quality Index of -3.03x as of September 2025. Operating cash flow of CN¥-15.07 Million is below net income of CN¥4.97 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 600513 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Lianhuan Pharmaceutical Co Ltd Cash Flow Quality Index (2002–2024)
Historical Cash Flow Quality Index for Jiangsu Lianhuan Pharmaceutical Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Jiangsu Lianhuan Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Year-by-year earnings quality comparison for Jiangsu Lianhuan Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥10.77 Million | CN¥106.42 Million | ▼ -90.5% |
| 2023 | 1.06x | CN¥160.70 Million | CN¥151.34 Million | ▲ +38.5% |
| 2022 | 0.77x | CN¥127.59 Million | CN¥166.44 Million | ▼ -22.5% |
| 2021 | 0.99x | CN¥138.34 Million | CN¥139.90 Million | ▲ +29.2% |
| 2020 | 0.77x | CN¥91.94 Million | CN¥120.15 Million | ▲ +745.4% |
| 2019 | -0.12x | CN¥-9.87 Million | CN¥83.25 Million | ▲ +90.4% |
| 2018 | -1.24x | CN¥-92.00 Million | CN¥74.17 Million | ▼ -2507.0% |
| 2017 | 0.05x | CN¥3.64 Million | CN¥70.56 Million | ▼ -95.4% |
| 2016 | 1.12x | CN¥70.28 Million | CN¥62.53 Million | ▼ -9.5% |
| 2015 | 1.24x | CN¥62.12 Million | CN¥50.01 Million | ▼ -21.5% |
| 2014 | 1.58x | CN¥69.50 Million | CN¥43.89 Million | ▲ +63.2% |
| 2013 | 0.97x | CN¥37.17 Million | CN¥38.32 Million | ▲ +64.1% |
| 2012 | 0.59x | CN¥16.94 Million | CN¥28.66 Million | ▼ -39.6% |
| 2011 | 0.98x | CN¥24.00 Million | CN¥24.51 Million | ▲ +135.1% |
| 2010 | 0.42x | CN¥8.43 Million | CN¥20.24 Million | ▼ -51.1% |
| 2009 | 0.85x | CN¥13.83 Million | CN¥16.24 Million | ▼ -36.7% |
| 2008 | 1.35x | CN¥17.44 Million | CN¥12.96 Million | ▲ +65.9% |
| 2007 | 0.81x | CN¥8.03 Million | CN¥9.90 Million | ▼ -36.8% |
| 2006 | 1.28x | CN¥10.14 Million | CN¥7.90 Million | ▲ +147.1% |
| 2005 | 0.52x | CN¥3.82 Million | CN¥7.36 Million | ▲ +10.2% |
| 2004 | 0.47x | CN¥3.39 Million | CN¥7.20 Million | ▲ +139.6% |
| 2003 | -1.19x | CN¥-13.19 Million | CN¥11.09 Million | ▼ -197.7% |
| 2002 | 1.22x | CN¥19.22 Million | CN¥15.78 Million | — |